Anti-Cancer Approved Drug Library

Ref. TM-L2110

Información del producto

• Nombre: Anti-Cancer Approved Drug Library

Descripción

A unique collection of 1825 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
- These FDA, EMA, or NMPA approved anti-cancer drugs have annotated bioactivity, safety, and bioavailability;
- Effective tool for cancer research and drug repurposing screening;
- Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc., in lung cancer, breast cancer, leukemia, lymphoma, etc.
- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;
- Structurally diverse, medicinally active, and cell permeable;
- NMR and HPLC validated to ensure high purity and quality;

• Marca: Targetmol